Javascript must be enabled to continue!
Therapeutic effect of mifepristone combined with misoprostol in early missed miscarriage and prediction of incomplete abortion
View through CrossRef
Objective:
To compare the clinical efficacy of mifepristonemisoprostol medical management versus surgical curettage for first-trimester missed miscarriage, and to establish evidence-based sonographic cutoff values predictive of incomplete abortion requiring surgical intervention.
Methods:
We retrospectively analyzed a cohort of 702 women diagnosed with first-trimester missed miscarriage between January 2020 and May 2023. Demographic characteristics and ultrasound parameters were systematically recorded. Receiver operating characteristic (ROC) curve analysis was performed to establish optimal sonographic cutoff values for predicting incomplete abortion requiring surgical intervention.
Results:
146 patients received medical treatment (mifepristone and misoprostol) and 556 underwent surgical curettage. At the 1-month follow-up, the medical group showed significantly greater endometrial thickness and longer postoperative bleeding duration than the surgical group (P<0.05). The menstrual volume reduction rate (23.56%) was significantly lower in the medical group than in the surgical group. The incomplete abortion rate was higher in the medical group (17.12%, 25/146) than in the surgical group (2.88%, 16/556). Among the medical group, 14 patients (9.59%) required curettage due to incomplete abortion, while 11 cases resolved spontaneously after prolonged medication. ROC curve analysis identified two cut-off values indicating the need for surgical intervention: endometrial thickness >1.21 cm at 24 h post-medical abortion, and residual mass diameter >0.95 cm at 7 days post-medical abortion.
Conclusions:
Medical management of first-trimester missed miscarriage using mifepristone-misoprostol demonstrates comparable efficacy to surgical curettage. An endometrial thickness >1.21 cm at 24 h or residual tissue diameter >0.95 cm at 7 days post-medical abortion should prompt consideration of incomplete abortion.
Ovid Technologies (Wolters Kluwer Health)
Title: Therapeutic effect of mifepristone combined with misoprostol in early missed miscarriage and prediction of incomplete abortion
Description:
Objective:
To compare the clinical efficacy of mifepristonemisoprostol medical management versus surgical curettage for first-trimester missed miscarriage, and to establish evidence-based sonographic cutoff values predictive of incomplete abortion requiring surgical intervention.
Methods:
We retrospectively analyzed a cohort of 702 women diagnosed with first-trimester missed miscarriage between January 2020 and May 2023.
Demographic characteristics and ultrasound parameters were systematically recorded.
Receiver operating characteristic (ROC) curve analysis was performed to establish optimal sonographic cutoff values for predicting incomplete abortion requiring surgical intervention.
Results:
146 patients received medical treatment (mifepristone and misoprostol) and 556 underwent surgical curettage.
At the 1-month follow-up, the medical group showed significantly greater endometrial thickness and longer postoperative bleeding duration than the surgical group (P<0.
05).
The menstrual volume reduction rate (23.
56%) was significantly lower in the medical group than in the surgical group.
The incomplete abortion rate was higher in the medical group (17.
12%, 25/146) than in the surgical group (2.
88%, 16/556).
Among the medical group, 14 patients (9.
59%) required curettage due to incomplete abortion, while 11 cases resolved spontaneously after prolonged medication.
ROC curve analysis identified two cut-off values indicating the need for surgical intervention: endometrial thickness >1.
21 cm at 24 h post-medical abortion, and residual mass diameter >0.
95 cm at 7 days post-medical abortion.
Conclusions:
Medical management of first-trimester missed miscarriage using mifepristone-misoprostol demonstrates comparable efficacy to surgical curettage.
An endometrial thickness >1.
21 cm at 24 h or residual tissue diameter >0.
95 cm at 7 days post-medical abortion should prompt consideration of incomplete abortion.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Health care providers’ perceptions of using misoprostol in the treatment of incomplete abortion in Malawi
Health care providers’ perceptions of using misoprostol in the treatment of incomplete abortion in Malawi
Abstract
Background
In Malawi, abortion is only legal to save a pregnant woman’s life. Treatment for complications after unsafe abortions has a mas...
Comparison of Mifepristone plus Misoprostol with Misoprostol Alone for First Trimester Medical Abortion: A Systematic Review & Meta -Analysis Protocol
Comparison of Mifepristone plus Misoprostol with Misoprostol Alone for First Trimester Medical Abortion: A Systematic Review & Meta -Analysis Protocol
Abstract
Background Original clinical trials have demonstrated that the combined mifepristone plus misoprostol has a marked effectiveness on first trimester abortion practi...
Medical termination for pregnancy in early first trimester (≤ 63 days): a systematic review
Medical termination for pregnancy in early first trimester (≤ 63 days): a systematic review
Abstract
Background A wide range of drugs have been studied for first trimester medical abortion. Studies evaluating different regimens, including combination mifepristone ...
Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
ObjectiveTo compare mifepristone plus a misoprostol-combined regimen with misoprostol alone in the medical abortion of first trimester pregnancy.MethodsAn internet-based search of ...
MIFEPRISTONE AND MISOPROSTOL VS MISOPROSTOL ALONE IN SECOND TRIMESTER TERMINATION OF PREGNANCY.
MIFEPRISTONE AND MISOPROSTOL VS MISOPROSTOL ALONE IN SECOND TRIMESTER TERMINATION OF PREGNANCY.
Introduction: During the last decade, medical methods for second trimester abortion have considerably improved and
become safe and more accessible. The combination of mifepristone ...
Obat Aborsi Bandung | WA : 0858 6506 9949 | Obat Penggugur Kandungan Bandung | Obat Telat Bulan Bandung | Obat Cytotec Bandung | Obat Pelancar Haid Bandung
Obat Aborsi Bandung | WA : 0858 6506 9949 | Obat Penggugur Kandungan Bandung | Obat Telat Bulan Bandung | Obat Cytotec Bandung | Obat Pelancar Haid Bandung
Jual Obat Aborsi Bandung | Obat Penggugur kandungan Bandung | Pil Aborsi Janin Bandung | Obat Pil Penggugur Kandungan Bandung | Alamat Klinik Jual Obat Aborsi Bandung | Apotik Jual...
Sublingual Misoprostol Versus Manual Vacuum Aspiration for Treatment of Incomplete Abortion in Nigeria: A Randomized Control Study
Sublingual Misoprostol Versus Manual Vacuum Aspiration for Treatment of Incomplete Abortion in Nigeria: A Randomized Control Study
Abstract
Objectives: To compare the effectiveness of single-dose sublingual misoprostol to manual vacuum aspiration in the treatment of incomplete spontaneous abortion in E...

